Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Vertex Pharmaceuticals Incorporated (VRTX)

176.08 1.12 (0.64%)

08-17 16:00

Open:

174.66

Pre. Close:

174.96

High:

176.99

Low:

173.59

Volume:

963,604

Market Cap:

44999M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

177.218 - 177.875

177.875 - 178.404

Low:

171.807 - 172.639

172.639 - 173.307

Close:

174.83 - 176.115

176.115 - 177.149

Technical analysis  (as of: 2018-08-17 4:31:33 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 207.93     One year: 214.20

Support:

Support1: 169.33    Support2: 140.88

Resistance:

Resistance1: 178.02    Resistance2: 183.39

Pivot:

175.49

Moving Averages:

MA(5): 175.00     MA(20): 175.43

MA(100): 162.18     MA(250): 158.05

MACD:

MACD(12,26): 1.21     Signal(12,26,9): 1.86

%K %D:

%K(14,3): 49.75     %D(3): 50.14

RSI:

RSI(14): 54.92

52-Week:

High: 183.39  Low: 136.5  Change(%): 18.2

Average Vol(K):

3-Month: 155321  10-Days 80172

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
VRTX has closed below upper band by 38.8%. Bollinger Bands are 69.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to VRTX's normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-08-16T10:04:00-04:00
Vertex Awards Two College Students Full Scholarships to the University of Massachusetts

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

255.56

Shares Float (M)

253.30

% Held by Insiders

0.90

% Held by Institutions

98.20

Shares Short (K)

2446

Shares Short Prior Month (K)

Stock Financials

EPS

1.720

EPS Est. Current Year

1.630

EPS Est. Next Year

2.890

EPS Est. Next Quarter

0.560

Forward EPS

4.511

Book Value (p.s.)

16.630

PEG Ratio

0.80

Profit Margin

9.56

Operating Margin

19.73

Return on Assets (ttm)

10.9

Return on Equity (ttm)

19.1

Qtrly Rev. Growth

38.2

Gross Profit (p.s.)

4.198

Sales Per Share

EBITDA (p.s.)

-0.660

Qtrly Earnings Growth

1052.30

Operating Cash Flow (M)

971.96

Levered Free Cash Flow (M)

556.14

Valuation

P/E

102.37

P/E Growth Ratio

0.01

P/BV

10.59

P/S

4326827008.00

P/CF

46.30

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.